{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:07:48Z","timestamp":1777961268119,"version":"3.51.4"},"reference-count":20,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2020,4,30]]},"DOI":"10.3233\/cbm-190187","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T13:00:33Z","timestamp":1584104433000},"page":"81-89","source":"Crossref","is-referenced-by-count":8,"title":["CYFRA 21-1 levels in cerebrospinal fluid as a putative therapeutic monitoring biomarker for patients with leptomeningeal carcinomatosis: A pilot study"],"prefix":"10.1177","volume":"28","author":[{"given":"Jae-Won","family":"Hyun","sequence":"first","affiliation":[{"name":"Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Shik","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Research Institute and Hospital of National Cancer Center, Goyang, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Hyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Young","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Research Institute and Hospital of National Cancer Center, Goyang, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heon","family":"Yoo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Research Institute and Hospital of National Cancer Center, Goyang, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Shin","family":"Gwak","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Research Institute and Hospital of National Cancer Center, Goyang, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/CBM-190187_ref1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.clinbiochem.2004.05.009","article-title":"Clinical utility of cytokeratins as tumor markers","volume":"37","author":"Barak","year":"2004","journal-title":"Clin Biochem"},{"key":"10.3233\/CBM-190187_ref2","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1850::AID-CNCR6>3.0.CO;2-R","article-title":"Evaluation of tissue polypeptide specific antigen, CYFRA 21-1 and carcinoembryonic antigen in non small cell lung carcinoma: Does the combined use of cytokeratin markers give an additional information","volume":"10","author":"Nisman","year":"1998","journal-title":"Cancer"},{"key":"10.3233\/CBM-190187_ref3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.lungcan.2012.11.006","article-title":"Preoperative serum CYFRA 21-1 level as a prognostic factor in surgically treated adenocarcinoma of lung","volume":"79","author":"Park","year":"2013","journal-title":"Lung Cancer"},{"key":"10.3233\/CBM-190187_ref4","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/bjc.2013.158","article-title":"Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer","volume":"108","author":"Boeck","year":"2013","journal-title":"Br J Cancer"},{"key":"10.3233\/CBM-190187_ref5","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/annonc\/mdq232","article-title":"Survival of breast cancer patients with meningeal carcinomatosis","volume":"21","author":"Gauthier","year":"2010","journal-title":"Ann Oncol"},{"key":"10.3233\/CBM-190187_ref6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11060-013-1244-x","article-title":"Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa","volume":"115","author":"Comte","year":"2013","journal-title":"J Neurooncol"},{"key":"10.3233\/CBM-190187_ref7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3233\/CBM-130338","article-title":"The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer","volume":"13","author":"Wang","year":"2013","journal-title":"Cancer Biomarkers"},{"key":"10.3233\/CBM-190187_ref8","doi-asserted-by":"crossref","first-page":"2467870","DOI":"10.1155\/2017\/2467870","article-title":"Diagnostic value of CYFRA 21-1 in the cerebrospinal fluid for leptomeningeal metastasis","volume":"2017","author":"Zhang","year":"2017","journal-title":"Dis Markers"},{"issue":"32","key":"10.3233\/CBM-190187_ref9","doi-asserted-by":"crossref","first-page":"53326","DOI":"10.18632\/oncotarget.18405","article-title":"Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis","volume":"8","author":"Hyun","year":"2017","journal-title":"Oncotarget"},{"key":"10.3233\/CBM-190187_ref10","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/CCO.0b013e32833de986","article-title":"Leptomeningeal metastasis","volume":"22","author":"Chamberlain","year":"2010","journal-title":"Curr Opin Oncol"},{"key":"10.3233\/CBM-190187_ref11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejca.2015.12.021","article-title":"Leptomeningeal metastasis: Clinical experience of 519 cases","volume":"56","author":"Hyun","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.3233\/CBM-190187_ref12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archneurol.2010.18","article-title":"New strategies in the management of leptomeningeal metastases","volume":"67","author":"Groves","year":"2010","journal-title":"Arch Neurol"},{"key":"10.3233\/CBM-190187_ref13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ana.410380111","article-title":"Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis","volume":"38","author":"Freilich","year":"1995","journal-title":"Ann Neurol"},{"key":"10.3233\/CBM-190187_ref14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0090-3019(95)00403-3","article-title":"Ventriculolumbar perfusion chemotherapy with methotrexate and cytosine arabinoside for meningeal carcinomatosis: A pilot study in 13 patients","volume":"45","author":"Nakagawa","year":"1996","journal-title":"Surg Neurol"},{"key":"10.3233\/CBM-190187_ref15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/COC.0b013e3182549643","article-title":"Ventriculolumbar perfusion chemotherapy for the treatment of leptomeningeal carcinomatosis: A phase I study with pharmacokinetic data","volume":"36","author":"Gwak","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.3233\/CBM-190187_ref16","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1634\/theoncologist.2014-0199","article-title":"Ventriculolumbar perfusion chemotherapy with methotrexate for treating leptomeningeal carcinomatosis: A phase II study","volume":"19","author":"Gwak","year":"2014","journal-title":"Oncologist"},{"key":"10.3233\/CBM-190187_ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3340\/jkns.2015.58.1.1","article-title":"Recent advancements of treatment for leptomeningeal carcinomatosis","volume":"58","author":"Gwak","year":"2015","journal-title":"J Korean Neurosurg Soc"},{"key":"10.3233\/CBM-190187_ref18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev-anchem-060908-155305","article-title":"Electrogenerated chemiluminescence","volume":"2","author":"Forster","year":"2009","journal-title":"Annu Rev Anal Chem"},{"key":"10.3233\/CBM-190187_ref19","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.6004\/jnccn.2015.0148","article-title":"Central nervous system cancers, version 1","volume":"13","author":"Nabors","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.3233\/CBM-190187_ref20","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1200\/JCO.1999.17.6.1825","article-title":"Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors","volume":"17","author":"Gajjar","year":"1999","journal-title":"J Clin Oncol"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-190187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:07:30Z","timestamp":1777385250000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-190187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":20,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/cbm-190187","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,30]]}}}